|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization and write-off of debt issuance costs | |||||
| Amortization of debt discount | |||||
| Provision for doubtful accounts | |||||
| (Gain) loss on sale of assets or stations | |||||
| Gain on sale of BMI | |||||
| Impairment of right-of-use assets | |||||
| Change in fair value of contingent consideration | |||||
| Impairment of intangible assets | |||||
| Impairment of capitalized software development costs | |||||
| Impairment of assets held for sale | |||||
| Deferred income taxes | |||||
| Stock-based compensation expense | |||||
| Gain on early extinguishment of debt | |||||
| Non-cash interest expense on financing liabilities | |||||
| Non-cash imputed rental income | |||||
| Changes in assets and liabilities (excluding acquisitions and dispositions): | |||||
| Accounts receivable | |||||
| Trade receivable | |||||
| Prepaid expenses and other current assets | |||||
| Operating leases, net | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Trade payable | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of assets or stations | |||||
| Asset acquisition | |||||
| Proceeds from sale of BMI | |||||
| Proceeds from insurance reimbursement | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of borrowings under Term Loan due 2026 | |||||
| Repayment of borrowings under Senior Notes due 2026 | |||||
| Treasury stock purchases | |||||
| Payment of contingent consideration | |||||
| Borrowings under the 2020 revolving credit facility | |||||
| Financing costs on Revolving Credit Agreement | |||||
| Shares returned in lieu of tax payments | |||||
| Repayments of financing liabilities | |||||
| Repayments of finance lease obligations | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...
